Dr. Andrew Pipe on the misconceptions of smoking cessation
In this series of videos, Dr. Andrew Pipe explains what we know about tobacco's powerful influence on the body and brain and describes the successful Ottawa model for smoking cessation.
Dr. Pipe is chief of the Division of Prevention and Rehabilitation at the University of Ottawa Heart Institute. His views on smoking and cessation have changed over his decades of practice as research uncovers the neurobiology of tobacco addiction and cessation. This series is from the Grand Rounds presentation to an audience of clinicians at the Centre for Addiction and Mental Health (CAMH) in Toronto in 2014, and includes a video of the entire presentation and shorter video chapters.
The zombies of smoking cessation
Dr. Andrew Pipe dispels the misconceptions of smoking cessation and describes the successful Ottawa model for smoking cessation.
Nicotine and addiction
Dr. Andrew Pipe describes how nicotine enters the body and leads to addiction.
Addressing tobacco use by psychiatric patients
Dr. Andrew Pipe explains why doctors need to address tobacco use among psychiatric patients.
Smoking and depression
Dr. Andrew Pipe explains the link betwen smoking and depression.
Smoking and schizophrenia
Dr. Andrew Pipe talks about smoking and schizophrenia.
Smoking and caffeine
Dr. Andrew Pipe explains how caffeine affects people who smoke.
Quit rates among psychiatric patients
Dr. Andrew Pipe talks about smoking cessation rates among psychiatric patients.
The Ottawa model of smoking cessation
Dr. Andrew Pipe describes the successful Ottawa model for systemic change in quitting smoking.
26 seconds to smoking cessation
Dr. Andrew Pipe explains how clinicians can support smoking cessation in 26 seconds.
Nicotine replacement therapy
Dr. Andrew Pipe talks about nicotine replacement therapy (NRT).
Bupropion and varenicline
Dr. Andrew Pipe explains the uses of bupropion and varenicline for smoking cessation.
Dr. Andrew Pipe explains the research on e-cigarettes.